関連する実験動画
オステオイド骨腫に対するPCトモグラフィー誘導の皮膚経熱凝固療法.
J C de Berg1, P M Pattynama, W R Obermann
1Department of Radiology, University Hospital, Leiden, Netherlands.
Lancet (London, England)
|August 5, 1995
まとめ
皮膚経熱凝固は,骨格性骨腫の有効で最小侵襲的な治療法を提供します. このCTガイドされた手順は,ほとんどの患者の痛みを成功裏に緩和し,外科的切除の安全な代替手段を提供しました.
関連する概念動画
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
Same author
Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2008
Same author
Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: explanation and potential clinical applications for color-coded qualitative and quantitative analysis.
Acta radiologica (Stockholm, Sweden : 1987)·2008
Same author
Nail-patella syndrome associated with Ewing sarcoma.
JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)·2007
Same author
[Percutaneous radiologic thermocoagulation treatment of liver, kidney and lung tumours].
Nederlands tijdschrift voor geneeskunde·2005
Same author
Second-generation, subsecond multislice computed-tomography: advancing the role of helical CT pulmonary angiography in suspected pulmonary embolism.
Seminars in vascular medicine·2004
Same author
Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma.
The Journal of clinical endocrinology and metabolism·2003
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026